Privium Fund Management B.V. — 13F Holdings & Portfolio

CIK 1795097 · latest 13F-HR filed 2026-08-07

Privium Fund Management B.V. manages $544.2M in 13F-reported U.S. long-equity assets across 61 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are TSLA (17.62%), SHOP (7.76%), AMD (6.62%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 12 new positions and exited 11; 29 existing positions rose in reported value and 16 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$544.2M

Long-equity book

Holdings
61

Distinct positions

Period
2026-06-30

Filed 2026-08-07

Q/Q Activity
+12 / −11 / ↑29 / ↓16

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

3 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 61.8%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Privium Fund Management B.V. Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 TESLA INC TSLA 88160R101 $95.9M 17.62% 228,000 SH
2 SHOPIFY INC SHOP 82509L107 $42.2M 7.76% 370,000 SH
3 ADVANCED MICRO DEVICES INC AMD 007903107 $36.0M 6.62% 62,000 SH
4 AMAZON COM INC AMZN 023135106 $33.4M 6.13% 140,000 SH
5 IONIS PHARMACEUTICALS INC IONS 462222100 $25.4M 4.66% 319,924 SH
6 SPOTIFY TECHNOLOGY S A SPOT L8681T102 $25.3M 4.64% 55,000 SH
7 PALANTIR TECHNOLOGIES INC PLTR 69608A108 $23.3M 4.29% 200,000 SH
8 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $19.1M 3.51% 234,222 SH
9 OPENDOOR TECHNOLOGIES INC OPEN 683712103 $18.2M 3.35% 3,940,904 SH
10 LEMONADE INC LMND 52567D107 $17.6M 3.23% 270,259 SH
11 NVIDIA CORPORATION NVDA 67066G104 $16.2M 2.98% 81,000 SH
12 IREN LIMITED IREN Q4982L109 $15.6M 2.86% 340,150 SH
13 UNIQURE NV QURE N90064101 $15.1M 2.78% 328,322 SH
14 CEREBRAS SYSTEMS INC CBRS 15675D103 $13.4M 2.46% 60,500 SH
15 AST SPACEMOBILE INC ASTS 00217D100 $12.9M 2.37% 145,000 SH
16 ULTRAGENYX PHARMACEUTICAL IN RARE 90400D108 $11.3M 2.08% 338,800 SH
17 ARCUTIS BIOTHERAPEUTICS INC ARQT 03969K108 $10.5M 1.92% 399,367 SH
18 BIOGEN INC BIIB 09062X103 $10.5M 1.92% 48,400 SH
19 PROQR THRAPEUTICS N V PRQR N71542109 $10.3M 1.89% 5,520,024 SH
20 AXSOME THERAPEUTICS INC. AXSM 05464T104 $9.8M 1.80% 39,944 SH
21 UROGEN PHARMA LTD URGN M96088105 $7.7M 1.42% 210,000 SH
22 SPACE EXPLORATION TECHN CORP SPCX 84615Q103 $6.8M 1.26% 40,000 SH
23 DENALI THERAPEUTICS INC DNLI 24823R105 $5.9M 1.09% 229,857 SH
24 VERTEX PHARMACEUTICALS INC VRTX 92532F100 $4.7M 0.86% 9,400 SH
25 BIOMARIN PHARMACEUTICAL INC BMRN 09061G101 $4.3M 0.79% 75,000 SH
26 KRYSTAL BIOTECH INC KRYS 501147102 $4.2M 0.76% 11,170 SH
27 ALNYLAM PHARMACEUTICALS INC ALNY 02043Q107 $3.4M 0.63% 11,372 SH
28 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $3.2M 0.59% 173,516 SH
29 BIONTECH SE BNTX 09075V102 $2.8M 0.51% 30,100 SH
30 HIMS & HERS HEALTH INC HIMS 433000106 $2.8M 0.51% 80,000 SH
31 MEIRAGTX HLDGS PLC MGTX G59665102 $2.6M 0.49% 196,112 SH
32 AMBEV SA ABEV 02319V103 $2.5M 0.46% 802,167 SH
33 SAREPTA THERAPEUTICS INC SRPT 803607100 $2.5M 0.45% 136,500 SH
34 CRISPR THERAPEUTICS AG CRSP H17182108 $2.5M 0.45% 44,974 SH
35 BEAM THERAPEUTICS INC BEAM 07373V105 $2.4M 0.44% 70,282 SH
36 ZAI LAB LTD ZLAB 98887Q104 $2.3M 0.43% 122,189 SH
37 MODERNA INC MRNA 60770K107 $2.1M 0.39% 29,994 SH
38 CARTESIAN THERAPEUTICS INC RNAC 816212302 $1.6M 0.29% 151,675 SH
39 MAGNUM ICE CREAM CO NV MICC N5505D105 $1.5M 0.27% 98,221 SH
40 WAVE LIFE SCIENCES LTD WVE Y95308105 $1.4M 0.26% 241,010 SH
41 TAYSHA GENE THERAPIES INC TSHA 877619106 $1.4M 0.25% 198,900 SH
42 ZOETIS INC ZTS 98978V103 $1.2M 0.23% 17,322 SH
43 4D MOLECULAR THERAPEUTICS IN FDMT 35104E100 $1.2M 0.22% 90,110 SH
44 FATE THERAPEUTICS INC FATE 31189P102 $1.1M 0.21% 414,311 SH
45 LEGEND BIOTECH CORP LEGN 52490G102 $1.0M 0.19% 35,400 SH
46 ROCKET PHARMACEUTICALS INC RCKT 77313F106 $835.0K 0.15% 244,146 SH
47 NOV INC NOV 62955J103 $779.6K 0.14% 42,026 SH
48 B2GOLD CORP BTG 11777Q209 $729.6K 0.13% 195,083 SH
49 TOTALENERGIES SE TTE F92124100 $729.5K 0.13% 10,723 SH
50 LEXEO THERAPEUTICS INC LXEO 52886X107 $722.3K 0.13% 155,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-07 $544.2M 61 0001754960-26-000698
2026-03-31 2026-05-05 $480.3M 60 0001754960-26-000356
2025-12-31 2026-02-03 $543.1M 57 0001754960-26-000150
Filer Information
Address
GUSTAV MAHLERPLEIN 3
AMSTERDAM, P7 1082 MS
Phone
31 20 462 6644
Filing Manager
Privium Fund Management B.V.
AMSTERDAM, P7
Signatory
Aryn Sands
Agent